Commerce Bank lessened its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 1.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 169,881 shares of the financial services provider's stock after selling 2,378 shares during the period. Commerce Bank's holdings in CME Group were worth $37,484,000 as of its most recent SEC filing.
Several other large investors have also made changes to their positions in CME. Capital International Investors raised its position in shares of CME Group by 24.1% in the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider's stock valued at $3,403,557,000 after purchasing an additional 3,069,806 shares during the period. PineStone Asset Management Inc. increased its position in shares of CME Group by 137.6% during the second quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider's stock valued at $444,443,000 after acquiring an additional 1,309,097 shares during the last quarter. Assenagon Asset Management S.A. boosted its position in shares of CME Group by 577.9% in the second quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider's stock valued at $126,872,000 after acquiring an additional 550,133 shares during the period. Ameriprise Financial Inc. boosted its stake in shares of CME Group by 11.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider's stock valued at $1,038,676,000 after purchasing an additional 537,758 shares in the last quarter. Finally, International Assets Investment Management LLC grew its stake in shares of CME Group by 21,465.5% in the third quarter. International Assets Investment Management LLC now owns 485,871 shares of the financial services provider's stock worth $1,072,070,000 after purchasing an additional 483,618 shares during the last quarter. Institutional investors own 87.75% of the company's stock.
Insider Transactions at CME Group
In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the company's stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. This represents a 12.01 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Martin J. Gepsman sold 400 shares of the firm's stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $222.92, for a total value of $89,168.00. Following the sale, the director now directly owns 25,067 shares in the company, valued at approximately $5,587,935.64. This represents a 1.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 15,621 shares of company stock worth $3,441,063. Insiders own 0.30% of the company's stock.
Analyst Ratings Changes
A number of analysts recently commented on the company. JPMorgan Chase & Co. upped their price objective on CME Group from $187.00 to $191.00 and gave the company an "underweight" rating in a research report on Thursday, July 25th. Redburn Atlantic lowered shares of CME Group from a "buy" rating to a "neutral" rating and set a $244.00 price objective for the company. in a research note on Tuesday, October 8th. The Goldman Sachs Group raised their price target on shares of CME Group from $195.00 to $198.00 and gave the stock a "sell" rating in a report on Thursday, October 3rd. Barclays upped their price target on shares of CME Group from $219.00 to $231.00 and gave the stock an "equal weight" rating in a research report on Thursday, October 24th. Finally, Royal Bank of Canada restated a "sector perform" rating and issued a $235.00 target price on shares of CME Group in a research report on Thursday, October 24th. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $224.47.
Check Out Our Latest Research Report on CME Group
CME Group Stock Down 0.8 %
CME stock traded down $1.75 during midday trading on Wednesday, hitting $227.91. The company's stock had a trading volume of 1,184,272 shares, compared to its average volume of 1,908,963. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $230.74. The firm has a market capitalization of $82.13 billion, a P/E ratio of 24.15, a PEG ratio of 5.20 and a beta of 0.55. The firm has a 50-day simple moving average of $223.02 and a 200-day simple moving average of $210.69.
CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, beating the consensus estimate of $2.65 by $0.03. The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm's revenue for the quarter was up 18.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.25 EPS. As a group, equities analysts forecast that CME Group Inc. will post 10.22 EPS for the current year.
CME Group Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be issued a dividend of $1.15 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.60 annualized dividend and a yield of 2.02%. CME Group's dividend payout ratio (DPR) is currently 48.37%.
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
